Načítá se...
Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments
MET, the receptor of hepatocyte growth factor, plays important roles in tumorigenesis and drug resistance in numerous cancers including non-small cell lung cancer. As increasing numbers of MET inhibitors are being developed for clinical applications, antibody fragment based immuno-positron emission...
Uloženo v:
| Vydáno v: | Mol Cancer Ther |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221648/ https://ncbi.nlm.nih.gov/pubmed/25143449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-14-0363 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|